Acute lymphoblastic leukemia

Seminars in Radiation Oncology

Volumn 7, Issue 3, 1997, Pages 185-194

  Kun, L E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIC MENINGITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TESTIS CANCER; TREATMENT OUTCOME;

EID: 0030746071     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(97)80002-1     Document Type: Conference Paper

References (92)

1. Pui C-H Childhood leukemias: Review article N Engl J Med 332 1995 1618 1630
2. Rivera GK Pinkel D Simone JV Treatment of acute lymphoblastic leukemia N Engl J Med 329 1993 1289 1295
3. Freeman AI Weinberg V Brecher ML Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children N Engl J Med 308 1983 477 841
4. Freeman AI Boyett JM Glicksman AS Intermediatedose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up Med Pediatr Oncol 28 1997 98 107
5. Riehm H Gadner H Henze G Results and significance of six randomized trials in four consecutive ALL-BFM studies Haematol Blood Transfus 33 1990 439 450
6. Niemeyer CM Gelber RD Tarbell NJ Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update) Blood 78 1991 2514 2519
7. Rivera GK Raimondi SC Hancock ML Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy Lancet 337 1991 61 66
8. Schorin MA Blattner S Gelber RD Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01 J Clin Oncol 12 1994 740 747
9. Smith M Arthur D Camitta B Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 14 1996 18 24
10. Reiter A Schrappe M Ludwig W-D Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86 Blood 84 1994 3122 3133
11. Pui C-H Behm FG Crist WM Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia Blood 82 1993 343 362
12. Steinherz P Siegel S Bleyer WA Lymphomatous presentation of acute lymphoblastic leukemia: A subgroup at high risk Cancer 68 1991 751 758
13. Cherlow JM Steinherz PG Sather HN The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: A report from the Children's Cancer Group Int J Radiat Oncol Biol Phys 27 1993 1001 1009
14. Conter V Arico M Valsecchi MG Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy J Clin Oncol 13 1995 2497 2502
15. Behm FG Raimondi SC Frestedt JL Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age Blood 87 1996 2870 2877
16. Shurtleff SA Buijs A Behm FG Tel/AML 1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis Leukemia 9 1995 1985 1989
17. Crist W Pullen J Boyett J Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: A Pediatric Oncology Group study Blood 67 1986 135 140
18. Chen C-S Sorensen PHB Domer PH Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome Blood 81 1993 2386 2393
19. Pui C-H Kane JR Crist WM Biology and treatment of infant leukemias Leukemia 9 1995 762 769
20. Mulhern RK Kovnar E Langston J Long-term survivors of leukemia treated in infancy: Factors associated with neuropsychologic status J Clin Oncol 10 1992 1095 1102
21. Lipshultz SE Colan SD Gelber RD Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
22. Mauer HS Steinherz PG Gaynon PS The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia J Clin Oncol 6 1988 1425 1432
23. Gajjar A Ribeiro R Hancock ML Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia Blood 86 1995 1292 1295
24. Steinherz PG Gaynon PS Breneman JC Cytoreduction and prognosis in acute lymphoblastic leukemia: The importance of early marrow response: Report from the Childrens Cancer Group J Clin Oncol 14 1996 389 398
25. Camitta B Mahoney D Leventhal B Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study J Clin Oncol 12 1994 1383 1389
26. Chessells JM Bailey C Richards SM for the Medical Research Council Working party on Childhood Leukaemia: Intensification of treatment and survival in all children with lymphoblastic leukaemia Results of UK Medical Research Council trial UKALLX Lancet 345 1995 143 148
27. Hustu HO Aur RJA Extramedullary leukaemia Clin Hematol 7 1978 313 337
28. Pinkel D Woo S Prevention and treatment of meningeal leukemia in children Blood 84 1994 355 366
29. Pullen J Boyett J Shuster J Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: A Pediatric Oncology Group Study J Clin Oncol 11 1993 839 849
30. Tubergen DG Gilchrist GS O'Brien RT Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Children's Cancer Group report J Clin Oncol 11 1993 520 526
31. Ingram LC Fairclough DL Furman WL Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma Cancer 67 1991 2262
32. Price RA Johnson WW The central nervous system in childhood leukemia: I. The arachnoid Cancer 31 1973 520 533
33. Mastrangelo R Poplack D Bleyer A Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment Med Pediatr Oncol 14 1986 191 194
34. Mahmoud HH Rivera GK Hancock ML Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia N Engl J Med 329 1993 314 319
35. Gelber RD Sallan SE Cohen HJ Central nervous system treatment in childhood acute lymphoblastic leukemia: Long-term follow-up of patients diagnosed between 1973 and 1985 Cancer 72 1993 261 270
36. Tubergen DG Cullen JW Boyett JM Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: A Children's Cancer Group study J Clin Oncol 12 1994 273 278
37. Gilchrist GS Tubergen DG Sather HN Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Children's Cancer Group study J Clin Oncol 12 1994 2594 2600
38. van den Berg H Vet R den Ouden E Significance of lymphoblasts in cerebrospinal fluid in newly diagnosed pediatric acute lymphoblastic malignancies with bone marrow involvement: Possible benefit of dexamethasone Med Pediatr Oncol 25 1995 22 27
39. Cherlow JM Sather H Steinherz P Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: A report from the Children's Cancer Group Int J Radiat Oncol Biol Phys 36 1996 19 27
40. Kun LE CNS disease at diagnosis: A continuing challenge in childhood lymphoblastic leukemia Int J Radiat Oncol Biol Phys 36 1996 257 259
41. Lauer S Shuster J Kirchner P Prognostic significance of cerebrospinal fluid (CSF) lymphoblasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL) Proc ASCO 13 1994 317
42. Bleyer WA Neurologic sequelae of methotrexate and ionizing radiation: A new classification Cancer Treat Rep 65 1981 89 98
43. Aur RJ Simone JV Hustu HO A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia Cancer 29 1972 381 391
44. Abromowitch M Ochs J Pui C-H High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X Med Pediatr Oncol 16 1988 297
45. Abromowitch M Ochs J Pui C-H Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: Analysis by contemporary risk classifications Blood 71 1988 866 869
46. Bleyer WA Poplack DG Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries Semin Oncol 12 1985 131
47. Land VJ Thomas PRM Boyett JM Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia: A Pediatric Oncology Group study Cancer 56 1985 81 87
48. Mahoney DH Nitschke R Lauer S Neurotoxicity (NT) in children with acute lymphoblastic leukemia (ALL) receiving intensive methotrexate (MTX) scheduled: A Pediatric Oncology Group (POG) study Proc ASCO 15 1996 366
49. Buhrer C Henze G Hofmann J Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials Haematol Blood Transfus 33 1990 500 503
50. Muller-Runkel R Vijayakumar S Therapeutic gain with hyperfractionation in prophylactic cranial irradiation of children with acute lymphoblastic leukemia Med Hypoth 39 1992 384 389
51. Tarbell N Waber D Cohen H Hyperfractionated cranial irradiation (HCI) in childhood acute lymphoblastic leukemia (ALL): Rationale and preliminary results Proc ASCO 10 1991 239
52. Riberio RC Rivera GK Hudson M An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia J Clin Oncol 13 1995 333 338
53. Kailov Y Optic nerve head infiltration in acute leukemia in children: An indication for emergency optic nerve radiation therapy Med Pediatr Oncol 26 1996 101 104
54. Schwartz CL Miller NR Wharam MD The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia Cancer 63 1989 1616 1620
55. Harnett AN Plowman PN The eye in acute leukemia: 2. The management of solitary anterior chamber relapse Radiother Oncol 10 1987 203 207
56. Bunin N Goode F Hustu HO Ocular relapse in the anterior chamber in childhood acute lymphoblastic leukemia J Clin Oncol 5 1987 299 303
57. George SL Ochs JJ Mauer AM The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia J Clin Oncol 3 1985 776 781
58. Winick NJ Smith SD Shuster J Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study J Clin Oncol 11 1993 271 278
59. Campana D Pui C-H Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance Blood 85 1995 1416 1434
60. Wells RJ Weetman RM Baehner RL The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemia J Pediatr 97 1980 429 432
61. Kun LE Camitta BM Mulhern RK Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: I. Results of craniospinal irradiation J Clin Oncol 2 1984 359
62. Mandell LR Steinherz P Fuks Z Delayed central nervous system (CNS) radiation in childhood CNS acute lymphoblastic leukemia: Results of a pilot trial Cancer 66 1990 447 450
63. Kumar P Kun LE Hustu HO Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia Int J Radiat Oncol Biol Phys 31 1995 477 483
64. Belasco J Goldwein J Lange B Monthly low-dose cranio-spinal (C-S) radiotherapy (RT) to 18 Gy after CNS relapse in children with acute lymphoblastic leukemia (ALL) Proc ASCO 15 1996 368
65. Behrendt H van Leeuwen EF Schuwirth C The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia Cancer 63 1989 2066 2072
66. Waber DP Tarbell NJ Kahn CM The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia J Clin Oncol 10 1992 810 817
67. Kumar P Mulhern RK Regine WF A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia Int J Radiat Oncol Biol Phys 31 1995 561 566
68. Mahoney DH Nitschke R Lauer S Neurotoxicity (NT) in children with acute lymphoblastic leukemia (ALL) receiving intensive methotrexate (MTX) schedules: A Pediatric Oncology Group (POG) study Proc ASCO 15 1996 366
69. Price RA Jamieson PA The central nervous system in childhood leukemia: II. Subacute leukoencephalopathy Cancer 35 1975 306
70. Ochs JJ Neurotoxicity due to central nervous system therapy for childhood leukemia Am J Pediatr Hematol Oncol 11 1989 93
71. Shalet SM Beardwell CG Pearson D The effect of varying doses of cerebral irradiation on growth hormone production in childhood Clin Endocrinol 5 1976 287
72. Robison LL Nesbit ME Jr Sather HN Height of children successfully treated for acute lymphoblastic leukemia: a report from the late effects study committee of Children's Cancer Study Group Med Pediatr Oncol 13 1985 14 21
73. Katz JA Pollock BH Jarcaruso BS Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia J Pediatr 123 1993 546
74. Williams JM Davis KS Central nervous system prophylactic treatment for childhood leukemia: Neuropsychological outcome studies Cancer Treat Rev 13 1986 113 127
75. Rubenstein CL Varni JW Katz ER Cognitive functioning in long-term survivors of childhood leukemia: A prospective analysis J Dev Behav Pediatr 11 1990 301 305
76. Ochs J Mulhern R Fairclough D Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study J Clin Oncol 9 1991 145 151
77. Roman DD Sperduto PW Neuropsychological effects of cranial radiation: Current knowledge and future directions Int J Radiat Oncol Biol Phys 31 1995 983 998
78. Peckham VC Meadows AT Bartel N Educational late effects in long-term survivors of childhood acute lymphoblastic leukemia Pediatrics 81 1988 127 133
79. Rimm IJ Li FC Tarbell NJ Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia: A 13-year experience from the Dana-Farber Cancer Institute and The Children's Hospital Cancer 59 1987 1506 1508
80. Neglia JP Meadows AT Robison LL Second neoplasms after acute lymphoblastic leukemia in childhood N Engl J Med 325 1991 1330 1336
81. (in press) Walter AW Hancock ML Hudson M Secondary brain tumors in children treated for acute lymphoblastic leukemia at St. Jude Children's Research Hospital J Clin Oncol 1997
82. Mulhern Rk Fairclough D Ochs J A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation J Clin Oncol 9 1991 1348 1356
83. Moore IM Kramer JH Wara W Cognitive function in children with leukemia: Effect of radiation dose and time since irradiation Cancer 68 1991 1913 1917
84. Ochs JJ Rivera G Aur RJ Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia J Clin Oncol 3 1985 622 626
85. Mulhern RK Ochs J Fairclough D Intellectual and academic achievement status after Cns relapse: A retrospective analysis of 40 children treated for acute lymphoblastic leukemia J Clin Oncol 5 1987 933 940
86. Longeway K Mulhern R Crisco J Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy Am J Pediatr Hem Oncol 12 1990 45 50
87. Bowman P Rhomes JA Aur H Isolated testicular relapse in acute lymphocytic leukemia of childhood: Categories and influence on survival J Clin Oncol 2 1984 924 929
88. Lampert F Henze G Langermann HJ Acute lymphoblastic leukemia: Current status of therapy in children Rec Res Cancer Res 93 1984 159 181
89. Wofford MM Smith SD Shuster JJ Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study J Clin Oncol 10 1992 624 630
90. Finklestein JZ Miller DR Feusner J Treatment of overt isolated testicular relapse in children on therapy for acute Lymphoblastic Leukemia: A report from the Children's Cancer Group Cancer 73 1994 219 223
91. Buchanan GR Boyett JM Pollock BH Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia: A Pediatric Oncology Group Study Cancer 68 1991 48 55
92. Blatt J Sherins RJ Niebrugge D Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia J Clin Oncol 3 1985 1227 1231